Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OBI-1 in Congenital Hemophilia A With Inhibitors
NCT01434511Phase 3Terminated
- Sponsor
- Takeda
- Start
- Oct 2011
- Primary completion
- Jul 2013
- Countries
- 3
01
Overview
A Phase 3 trial of susoctocog alfa in hemophilia A, sponsored by Takeda. Started Oct 2011; status: terminated.
02
Drugs
susoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01434511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01434511.